Navigation Links
Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium

Conference Features Renowned Translational Cancer Researchers and Updates on Key Discoveries, Plus Panel Discussion with Academic and Industry Leaders

NEW YORK, April 8 /PRNewswire-USNewswire/ -- Internationally renowned physician-scientists will discuss the rapidly changing cancer research landscape in the US, plus important recent discoveries in translational cancer research, during the first Damon Runyon Cancer Research Foundation Clinical Investigator Symposium.

The April 27th event, to be held in partnership with the New York Academy of Sciences, includes a panel discussion on the evolving partnership between academia and industry in research and drug development.


  • Robert A. Weinberg, Ph.D., of the Whitehead Institute and MIT, will deliver the keynote address focusing on the molecular basis of malignancy. Dr. Weinberg is one of the nation's most distinguished cancer researchers, most widely known for his pioneering discovery of the first human oncogene (Ras).
  • A panel discussion titled "Moving from Discovery through Development - The Evolving Relationship between Academia and Industry." Panel participants include senior scientists from leading academic cancer centers and representatives from industry:
  • Jakob Dupont, M.D., Medical Director, BioOncology, Genentech, Inc.;
  • Richard B. Gaynor, M.D., VP, Cancer Research and Global Oncology, Eli Lilly and Co.;
  • John Mendelsohn, M.D., President, M.D. Anderson Cancer Center;
  • Donald W. Rucker, M.D., VP and Chief Medical Officer, Siemens Medical Solutions USA;
  • Charles L. Sawyers, M.D., Chairman of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center.
  • Damon Runyon Clinical Investigators, a select group of innovative physician-scientists funded through the Damon Runyon Clinical Investigator Award program, will discuss their groundbreaking translational research, covering a broad range of topics including the latest work in cancer prevention, biomarkers, cancer stem cells and immunotherapy.

Presenting Damon Runyon Clinical Investigators include:

The symposium marks the 10th anniversary of the prestigious Damon Runyon Clinical Investigator Award, which addresses the critical demand for physicians capable of translating scientific discovery into new breakthroughs for cancer patients.

Media coverage of this event is encouraged.

    Catherine Bright
    Damon Runyon Cancer Research Foundation
    212.455.0506 or

    Bill Silberg
    New York Academy of Sciences
    212.298.8646 or

To see the event detail page, including agenda, speaker bios, scientific advisory committee and sign-up info, go to

Damon Runyon Cancer Research Foundation

The Damon Runyon Cancer Research Foundation's mission is to find the most brilliant and promising scientists and provide them with funding to pursue innovative research that will eliminate cancer as a deadly disease. Our strategy is to:

  • Recruit the best and brightest early-career scientists into cancer research.
  • Accelerate the translation of scientific discoveries into new diagnostic tools and treatments.
  • Enable risk-taking on bold new ideas.

Eleven scientists supported by the Foundation have received the Nobel Prize. Since 1946, the Foundation has invested over $220 million and funded more than 3,200 scientists.

100% of all donations to the Foundation are used to support scientific research. Administrative and fundraising costs are paid from its Damon Runyon Broadway Tickets Service and endowment.

The Damon Runyon Clinical Investigator Award selects top early-career physician-scientists conducting patient-oriented cancer research and provides them with the resources and training essential to becoming leaders in this important field. Since 2000, the Foundation has committed more than $30 million to support 44 exceptional physician-scientists from across the United States.

For more information visit

New York Academy of Sciences:

Founded in 1817, the New York Academy of Sciences (NYAS) is an independent, nonprofit organization committed to advancing science, technology, and society worldwide. With about 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.

SOURCE Damon Runyon Cancer Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NIH grant to strengthen IU and Purdue program to educate physician-scientists
2. NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting
3. NYP/Columbia physician-scientists present at ASCO 44th annual meeting
4. BWF awards $11.2 million to support physician-scientists
5. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
6. Best-selling authors and physicians from NYP/Weill Cornell discuss diet, surgery and bone health
7. Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results
8. CVS Caremark Discusses Role of Health IT to Optimize Pharmacy Health Care
9. HCSC Discusses the Controversial ICD-10 Transition at the 2009 HIMSS Conference
10. Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco
11. AMERIGROUP Corporation to Discuss First Quarter Earnings on May 1
Post Your Comments:
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... to a new study by UPMC and KingMed Diagnostics ... over three years found that consultation with UPMC pathologists resulted in significantly altered ...
(Date:11/30/2015)... ... , ... Two years ago, Debbie Gregory, the CEO of, found herself ... Meditation (TM). After encouraging a number of veterans to go through the program, ... the talk. , TM is becoming one of the best alternative treatments for Post-Traumatic ...
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... ... ... While powdered supplements and drinks can reduce food preparation time, locating the ... has found an easy to keep track of the scoop. , He developed a ... a canister or other container handy and readily accessible. As such, it prevents the ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an interview with Andy Mitchell ... top ophthalmologist on Long Island’s east end. During the broadcast, entitled “Eyes: the Window ... treatment of glaucoma and cataracts, and how a visit with his grandmother to her ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... PUNE, India , November 30, ... --> --> ... deal trends for 2010 - 2015 ... activity for a range of deal ... (M&A) and strategic alliances. ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... ST. LOUIS , Nov. 30, 2015  Premera ... today announced an early renewal of the companies, long-standing ... will now extend through at least 2019. ... pharmacy benefit manager capabilities during a competitive review and ... offer the best health plan integration and deliver the ...
Breaking Medicine Technology: